The podcast features Dr. Kelly Halderman and Dr. Suzanne Turner discussing the use of Low Dose Naltrexone (LDN) in managing thyroid health and its impact on inflammation and autoimmune responses
Dr. Suzanne Turner, an expert in cellular medicine, talks about her practice in Alpharetta, Georgia, and her approach to thyroid patients, focusing on underlying causes rather than just symptom management
LDN, or Low Dose Naltrexone, is discussed as a potential tool for managing thyroid-related inflammation and autoimmune issues. It's administered at low doses (around 3-4 milligrams) and works by decreasing inflammation in cells, potentially reducing antibodies that attack thyroid tissue
Dr. Kelly Halderman is a former physician turned biotech expert. She currently serves as Chief Health Officer for Weo – a health-conscious biotech company that uses patented technology to transform and perfect the most precious...
Dr. Turner is the founder of Vine Medical Associates and the VMA Residency. Double Board Certified, her thriving practice treats executives and athletes from around the world. Practicing Cellular, Longevity and Performance Medicine, Dr. Turner...